Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,522 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cholangiocarcinoma 2020: the next horizon in mechanisms and management.
Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, Cardinale V, Carpino G, Andersen JB, Braconi C, Calvisi DF, Perugorria MJ, Fabris L, Boulter L, Macias RIR, Gaudio E, Alvaro D, Gradilone SA, Strazzabosco M, Marzioni M, Coulouarn C, Fouassier L, Raggi C, Invernizzi P, Mertens JC, Moncsek A, Rizvi S, Heimbach J, Koerkamp BG, Bruix J, Forner A, Bridgewater J, Valle JW, Gores GJ. Banales JM, et al. Among authors: khan sa. Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):557-588. doi: 10.1038/s41575-020-0310-z. Epub 2020 Jun 30. Nat Rev Gastroenterol Hepatol. 2020. PMID: 32606456 Free PMC article. Review.
p53 Mutations in human cholangiocarcinoma: a review.
Khan SA, Thomas HC, Toledano MB, Cox IJ, Taylor-Robinson SD. Khan SA, et al. Liver Int. 2005 Aug;25(4):704-16. doi: 10.1111/j.1478-3231.2005.01106.x. Liver Int. 2005. PMID: 15998419 Review.
Cholangiocarcinoma.
Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Khan SA, et al. Lancet. 2005 Oct 8;366(9493):1303-14. doi: 10.1016/S0140-6736(05)67530-7. Lancet. 2005. PMID: 16214602 Review.
Differences in phosphatidylcholine and bile acids in bile from Egyptian and UK patients with and without cholangiocarcinoma.
Hashim Abdalla MS, Taylor-Robinson SD, Sharif AW, Williams HR, Crossey MM, Badra GA, Thillainayagam AV, Bansi DS, Thomas HC, Waked IA, Khan SA. Hashim Abdalla MS, et al. Among authors: khan sa. HPB (Oxford). 2011 Jun;13(6):385-90. doi: 10.1111/j.1477-2574.2011.00296.x. Epub 2011 Mar 22. HPB (Oxford). 2011. PMID: 21609370 Free PMC article.
Genetic factors in the pathogenesis of cholangiocarcinoma.
Wadsworth CA, Dixon PH, Wong JH, Chapman MH, McKay SC, Sharif A, Spalding DR, Pereira SP, Thomas HC, Taylor-Robinson SD, Whittaker J, Williamson C, Khan SA. Wadsworth CA, et al. Among authors: khan sa. Dig Dis. 2011;29(1):93-7. doi: 10.1159/000324688. Epub 2011 Jun 17. Dig Dis. 2011. PMID: 21691113 Free PMC article.
Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update.
Khan SA, Davidson BR, Goldin RD, Heaton N, Karani J, Pereira SP, Rosenberg WM, Tait P, Taylor-Robinson SD, Thillainayagam AV, Thomas HC, Wasan H; British Society of Gastroenterology. Khan SA, et al. Gut. 2012 Dec;61(12):1657-69. doi: 10.1136/gutjnl-2011-301748. Epub 2012 Aug 15. Gut. 2012. PMID: 22895392
The palliation of cholangiocarcinoma.
Shariff MI, Khan SA, Westaby D. Shariff MI, et al. Among authors: khan sa. Curr Opin Support Palliat Care. 2013 Jun;7(2):168-74. doi: 10.1097/SPC.0b013e32835f1e2f. Curr Opin Support Palliat Care. 2013. PMID: 23422512 Review.
Endoscopic radiofrequency ablation for cholangiocarcinoma.
Wadsworth CA, Westaby D, Khan SA. Wadsworth CA, et al. Among authors: khan sa. Curr Opin Gastroenterol. 2013 May;29(3):305-11. doi: 10.1097/MOG.0b013e32835faacc. Curr Opin Gastroenterol. 2013. PMID: 23449026 Review.
3,522 results